Ami Organics Limited announced the outcome of its Board Meeting held on May 2, 2025.

• The Board approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2025.
• For the financial year 2024-25 (FY25), the Consolidated Revenue from operations was ₹ 1,006.88 crore, up from ₹ 717.47 crore in FY24. Consolidated Profit for the year stood at ₹ 160.42 crore in FY25, significantly higher than ₹ 48.71 crore in FY24. Consolidated Basic EPS for FY25 was ₹ 19.81 (adjusted for split).
• For the quarter ended March 31, 2025 (Q4 FY25), Consolidated Revenue from operations was ₹ 308.48 crore, compared to ₹ 224.96 crore in Q4 FY24. Consolidated Profit for the quarter was ₹ 62.72 crore, up from ₹ 25.68 crore in Q4 FY24. Consolidated Basic EPS for Q4 FY25 was ₹ 7.80.
• The Board recommended a Final Dividend of ₹ 1.5/- (Rupees One and fifty paise only) per Equity Share of ₹ 5/- each (30%) for the financial year 2024-25. This dividend is subject to the approval of shareholders at the ensuing Annual General Meeting.
• The Board also approved the re-appointment of M/s Chirag Vallabhbhai Vekariya & Co. as Cost Auditors for FY 2025-26.
• The announcement also noted the Board's prior approval (April 16, 2025) for changing the company name to "Acutaas Chemicals Limited", subject to approvals.
• Details regarding the utilisation of proceeds from the Preferential Issue (₹ 99.10 crore raised in May 2024) and Qualified Institutional Placement (QIP) (₹ 400 crore raised in June 2024) were provided, indicating full utilisation of QIP funds and partial utilisation of preferential issue funds with extended timeline for the remaining.
• The EPS figures have been adjusted to reflect the 1:2 share split (face value ₹ 10 to ₹ 5) that became effective on April 25, 2025.